In this issue:

  • Loop + thiazide diuretics for acute HF across eGFR spectrum
  • Dapagliflozin for HF and deteriorating renal function
  • Repurposing mirabegron for structural cardiac disease
  • Natriuresis-guided diuretic therapy in acute HF
  • Novel HF progression pathways
  • Eliminating CaMKIIδ autophosphorylation improves HF survival and cardiac function
  • GLS predicts clinical outcomes in HFPEF
  • Intra-aortic entrainment pump for acute decompensated HF + cardiorenal syndrome
  • Health and economic evaluation of sacubitril-valsartan in HF management
  • Association of smartwatch- measured activity with patient- reported outcomes for HF

Download the Heart_Failure_Research_Review_Issue_82 with commentary by Dr Mark Nolan.